Screener
Aquestive Therapeutics, Inc. AQST Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s current ratio?
- Aquestive Therapeutics, Inc. (AQST) reported current ratio of 7.2× in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s current ratio changed year-over-year?
- Aquestive Therapeutics, Inc.'s current ratio increased by 103.8% year-over-year, from 3.5× to 7.2×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s current ratio has grown at a 8.2% compound annual growth rate (CAGR), from 2.1× to 3.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Aquestive Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude